There are currently a number of technologies and processes available to extract stem cells from lipoaspirate, but the vast majority of them utilize an enzyme to separate the regenerative cells from the adipose tissue. Some are very expensive to purchase and require costly per-treatment supplies. By incorporating multiple steps involved in the introduction of an enzyme into the lipoaspirate, then washing out the enzyme from the remaining cells before reinjection into the patient, those processes are considered to be excessive manipulation of the tissue which creates potential opposition from the FDA.

SkinBusiness offers a simple and innovative solution to this issue by offering a process that does not involve the use of enzymes, but has been clinically proven to deliver a higher number of regenerative cells than other processes. Not only is this process simple, it requires just 35 to 45 minutes to perform, has a very low per-treatment consumable cost and is far less expensive to acquire.

* Regenerative Cell Therapies are not currently approved by the FDA.